C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2724331
The invention relates to methods for predicting the outcome of rectal cancer and stratifying a rectal cancer treatment according to the level of DNA methylation at MINT 1, 3, 12, or 17.
L'invention concerne des méthodes permettant de prédire l'issue d'un cancer rectal et de stratifier le traitement d'un cancer rectal selon le taux de méthylation de MINT 1, 3, 12 ou 17.
de Matt Michiel F. G.
Hoon Dave S. B.
John Wayne Cancer Institute
Smart & Biggar
LandOfFree
Use of methylation status of mint loci as a marker for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of methylation status of mint loci as a marker for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of methylation status of mint loci as a marker for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1715498